Literature DB >> 3974825

Intracranial space-occupying lesions in acquired immune deficiency syndrome patients.

R B Snow, M H Lavyne.   

Abstract

The recent description of the acquired immune deficiency syndrome (AIDS) followed the observation of an increased incidence of unusual neoplasms and opportunistic infections in previously healthy homosexual men, intravenous drug abusers, Haitians, hemophiliacs, and certain infants. Active research efforts on this group of patients established a defect in cellular immunity. Six patients with AIDS who underwent neurosurgical procedures for intracranial space-occupying lesions are presented. Two of the patients had toxoplasmosis brain abscesses, one had primary central nervous system lymphoma, one had cytomegalovirus encephalitis, one had progressive multifocal leukoencephalopathy, and one patient remained undiagnosed despite pathological examination of the brain tissue specimen. We recommend brain biopsy in AIDS patients with space-occupying lesions because the regimen for the various conditions differs. Although the central nervous system diseases found in AIDS patients are associated with a high mortality rate, four of the six patients responded favorably to specific treatment.

Entities:  

Mesh:

Year:  1985        PMID: 3974825     DOI: 10.1227/00006123-198502000-00004

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  2 in total

1.  Nervous system manifestations and neuroradiologic findings in acquired immunodeficiency syndrome (AIDS).

Authors:  G Rodesch; P M Parizel; C M Farber; B Lalmand; S Przedborski; J D'Haens; M van Calck; A Vanderhofstadt; H Taelman; D Baleriaux
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

2.  Comparative analysis of intrathecal antibody synthesis and DNA amplification for the diagnosis of cytomegalovirus infection of the central nervous system in AIDS patients.

Authors:  T Weber; R Beck; E Stark; J Gerhards; K Korn; J Haas; W Lüer; G Jahn
Journal:  J Neurol       Date:  1994-06       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.